UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem Cells

Molecular cell, 2012-04, Vol.46 (1), p.30-42

2012

Volltextzugriff (PDF)

Regulation of MicroRNA Expression and Abundance during Lymphopoiesis

Immunity (Cambridge, Mass.), 2010-06, Vol.32 (6), p.828-839

2010

Volltextzugriff (PDF)

A Genome-wide Map of CTCF Multivalency Redefines the CTCF Code

Cell reports (Cambridge), 2013-05, Vol.3 (5), p.1678-1689

2013

Volltextzugriff (PDF)

Increased Mammalian Lifespan and a Segmental and Tissue-Specific Slowing of Aging after Genetic Reduction of mTOR Expression

Cell reports (Cambridge), 2013-09, Vol.4 (5), p.913-920

2013

Volltextzugriff (PDF)

CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer

PLoS genetics, 2021-05, Vol.17 (5), p.e1009553-e1009553

2021

Volltextzugriff (PDF)

p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells

Stem cells (Dayton, Ohio), 2015-04, Vol.33 (4), p.1304-1319

2015

Volltextzugriff (PDF)

Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence

PLoS genetics, 2022-06, Vol.18 (6), p.e1010271-e1010271

2022

Volltextzugriff (PDF)

Conventional Co-Housing Modulates Murine Gut Microbiota and Hematopoietic Gene Expression

International journal of molecular sciences, 2020-08, Vol.21 (17), p.6143

2020

Volltextzugriff (PDF)

WDR26 and MTF2 are therapeutic targets in multiple myeloma

Journal of hematology and oncology, 2021-12, Vol.14 (1), p.203-7, Article 203

2021

Volltextzugriff (PDF)

Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production

Blood, 2011-01, Vol.117 (4), p.1228-1238

2011

Volltextzugriff (PDF)

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation

Molecular cancer therapeutics, 2017-09, Vol.16 (9), p.2008-2021

2017

Volltextzugriff (PDF)

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development

The Journal of experimental medicine, 2008-09, Vol.205 (9), p.1949-1957

2008

Volltextzugriff (PDF)

3D chromatin architecture, BRD4, and Mediator have distinct roles in regulating genome-wide transcriptional bursting and gene network

Science advances, 2024-08, Vol.10 (32), p.eadl4893

2024

Volltextzugriff (PDF)

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells

Blood, 2011-12, Vol.118 (26), p.6803-6813

2011

Volltextzugriff (PDF)

Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2 , and PTK6 as sensitizing targets of rapamycin activity

Cancer letters, 2014-11, Vol.354 (2), p.336-347

2014

Volltextzugriff (PDF)

cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma

Stem cell reports, 2017-06, Vol.8 (6), p.1630-1644

2017

Volltextzugriff (PDF)

Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation

Proceedings of the National Academy of Sciences - PNAS, 2012-07, Vol.109 (27), p.10972-10977

2012

Volltextzugriff (PDF)

Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility

Blood, 2009-10, Vol.114 (14), p.2952-2960

2009

Volltextzugriff (PDF)

Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus

Proceedings of the National Academy of Sciences - PNAS, 2012-08, Vol.109 (34), p.13728-13732

2012

Volltextzugriff (PDF)

Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility

Molecular and Cellular Biology, 2001-01, Vol.21 (1), p.310-318

2001

Volltextzugriff (PDF)

The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility

The Journal of biological chemistry, 2019-11, Vol.294 (45), p.16756-16764

2019

Volltextzugriff (PDF)

FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells

Communications biology, 2020-10, Vol.3 (1), p.545-545, Article 545

2020

Volltextzugriff (PDF)

Conditional deletion of mTOR discloses its essential role in early B‐cell development

Molecular carcinogenesis, 2022-04, Vol.61 (4), p.408-416

2022

Volltextzugriff (PDF)

Frap, FKBP12 Rapamycin-Associated Protein, Is a Candidate Gene for the Plasmacytoma Resistance Locus Pctr2 and Can Act as a Tumor Suppressor Gene

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (25), p.14982-14987

2003

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(165)

Publikationsform

Sprache

Englisch
(185)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem Cells

Regulation of MicroRNA Expression and Abundance during Lymphopoiesis

A Genome-wide Map of CTCF Multivalency Redefines the CTCF Code

Increased Mammalian Lifespan and a Segmental and Tissue-Specific Slowing of Aging after Genetic Reduction of mTOR Expression

CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer

p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells

Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence

Conventional Co-Housing Modulates Murine Gut Microbiota and Hematopoietic Gene Expression

WDR26 and MTF2 are therapeutic targets in multiple myeloma

Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development

3D chromatin architecture, BRD4, and Mediator have distinct roles in regulating genome-wide transcriptional bursting and gene network

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells

Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2 , and PTK6 as sensitizing targets of rapamycin activity

cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma

Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation

Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility

Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus

B Cell Super-Enhancers and Regulatory Clusters Recruit AID Tumorigenic Activity

Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility

The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility

FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells

Conditional deletion of mTOR discloses its essential role in early B‐cell development

Frap, FKBP12 Rapamycin-Associated Protein, Is a Candidate Gene for the Plasmacytoma Resistance Locus Pctr2 and Can Act as a Tumor Suppressor Gene

Suchergebnisse filtern